Uterine cervical cancer
Conditions
Interventions
TP therapy (cicplatin, paclitaxel)
Sponsors
Department of Obstetrics and Gynecology Osaka City Iniversity Graduate School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Postoperative patients with uterine cervical cancer stage I-II. (1)who are diagnosed as uterine cervical cancer pathologically. (2)who are underwent radical hysterectomy and have risk factors for recurrens written below. 1. more than 1/2 invasion to cervical stroma and lymphovascular invasion 2. more than 2/3 invasion to cervical stroma 3. Lymph node metastasis 4. invasion to parametrium (3)no history of treatment other than surgery for uterine cervical cancer (4)age, over 20years old and under 75 years old. (5)Performance Status: 0-1 (6)normal function of organ (bone marrow, heart,liver, kidney) (7)written informed consent is obtained (8)who can start chemotherapy within six weeks from the surgery.
Exclusion criteria
Exclusion criteria: (1) who has severe infection after operation. (2)who has severe complicarion. (3)who has other cancer. (4)who has interstitial pneumonia or pulmonary fibrosis. (5)who have ascirtes or pleural infussion which need treatment. (6)who has the administration contraindication to cisplatin or paclitaxel. (7)who is severe allergic to drug. (8)who is considered inappropriate to this study by attending doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| two years disease free survival rate | — |
Countries
Japan
Contacts
Public ContactTakeshi Fukuda
Osaka City University Graduate School of Medicine Obstetrics and Gynecology
Outcome results
None listed